ImmunoGen won accelerated FDA approval for ... but there are many other examples, including MSD’s recent decision to license three ADCs from Daiichi Sankyo for $4 billion upfront and a total ...
In 2014, ImmunoGen, Inc. (Immunogen) filed U.S. Patent Application No. 14/509,809 (the ’809 application). 1 The ’809 application has three independent claims, all of which are directed to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results